Navigation Links
Sangart Completes Enrollment in Phase III Study of Its Novel Blood Substitute Hemospan
Date:3/24/2008

SAN DIEGO, Calif., March 24 /PRNewswire/ -- Sangart, Inc., a privately held biopharmaceutical company focused on the research, development and commercialization of blood substitutes, today announced that it has completed enrollment in a Phase III trial of its lead product Hemospan(R).

The completed study of 460 patients is one of two parallel Phase III clinical trials being conducted at 36 academic medical centers in the United Kingdom, Sweden, the Netherlands, Belgium, Poland and the Czech Republic. The two randomized, placebo-controlled studies, which will enroll a combined total of more than 800 elective orthopedic surgery patients, are designed to evaluate the safety and efficacy of Hemospan in preventing and treating hemodynamic instability, especially hypotension, or low blood pressure, during surgery.

"We are pleased to have completed enrollment in this Phase III study," said Dr. Robert Winslow, Chairman, President and CEO of Sangart. "This represents a major milestone for Sangart as we continue to gather evidence of Hemospan's potential to satisfy the significant and growing demand for a safe and effective agent to improve oxygen transport in clinical settings where blood is often transfused."

Sangart also announced that enrollment in the second Phase III study is progressing well and is expected to be completed in the near future.

No similar oxygen transport agents are currently on the market in Europe or the United States. Earlier clinical studies indicate that Hemospan's novel oxygen delivery mechanism has the potential to provide a safe and effective alternative to blood transfusions.

About Sangart

Sangart is a privately held San Diego-based biopharmaceutical company focused on the research, development and commercialization of medical products designed for use as alternatives to blood transfusions.

Dr. Robert Winslow, a world-renowned authority in the field of oxygen transport, founded Sangart in 1
'/>"/>

SOURCE Sangart, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
2. Sangart, Inc. Initiates Dosing in Phase II Study of Hemospan(R) in Chronic Critical Limb Ischemia
3. NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis
4. VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial
5. Alexion Completes Enrollment in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
6. Peptimmune Completes Phase I Study with a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis
7. NanoBio Corporation Successfully Completes Phase 2b Study in Herpes Labialis
8. Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis
9. Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study
10. NanoBio(R) Corporation Completes $30 Million in Equity Funding by Meeting Key Development Milestones
11. Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...ITY, Nov. 27 Booth - 364...E: VAR ), a premier supplier of X-ray tubes and ...ts full range of detectors at the RSNA Annual Meet..., 2009. Varian will also be exhibiting X-ray tube...cialized cancer treatment technologies. ,, Var...
(Date:11/26/2009)...RG, South Africa, Nov. 26 The 2009...Year Award in the Generic Pharmaceutical Market is..., (Logo: http://www.newscom.com/cgi-bin/prnh/2... Award, the following criteria were used to benchm...tors: growth strategy and implementation, degree o...
(Date:11/25/2009)...olo., Nov. 25 Heska Corp... advanced diagnostic and specialty products to th...with Roche Diagnostics Corporation for the supply ...or the veterinary market. ,, (Logo: http:/... ,, "Heska and Roche share the same passion for...
Breaking Medicine Technology:Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Oncolytics Biotech 28R 29 Inc Announces Issuance of 32nd U S Patent 13754 1Oncolytics Biotech 28R 29 Inc Announces Issuance of 32nd U S Patent 13754 2VillageReach Foundation for Community Development and Oasis Fund Announce Strategic Investment in Mozambique Social Business 55816 1VillageReach Foundation for Community Development and Oasis Fund Announce Strategic Investment in Mozambique Social Business 55816 2VillageReach Foundation for Community Development and Oasis Fund Announce Strategic Investment in Mozambique Social Business 55816 3VillageReach Foundation for Community Development and Oasis Fund Announce Strategic Investment in Mozambique Social Business 55816 4AEterna Zentaris to Present at Upcoming Rodman Renshaw Annual Global Investment Conference 13752 1
...nse to the President,s actions today changing fede...Zanotti, CEO of the American Policy Roundtable and...for the Roundtable, issued the following statement...o understand in light of years of progress in the ... stem cell research is frozen in failure all over ...
...RNA Administered in Humans and Quark,s Proprietary...uark Pharmaceuticals, Inc., a development-stage ph...vel RNA interference (RNAi)-based therapeutics, to...President, Pharmaceutical Development presented an...iRNA compounds at the Asia TIDES Oligonucleotide a...
Other Medicine Technology:Quark Pharmaceuticals Presents at Asia TIDES Conference 2Quark Pharmaceuticals Presents at Asia TIDES Conference 3
(Date:11/27/2009)... anatomy education apps from Modality and Lippinco...earning opportunities for iPhone and iPod touch ,...er 27, 2009 -- Modality, Inc. and Lippincott Wil...luwer Health, today announced the availability of ... Clemente’s Anatomy, Rohen’s Photograp...
(Date:11/26/2009)... living with diabetes will nearly double, increasi...34. Over the same period, spending on diabetes wil...billion, even with no increase in the prevalence o...Chicago report in the December issue of Diabetes ...ed by Medicare will rise from 8.2 million to 14.6 ...
(Date:11/26/2009)...ollercoaster, study finds , , THURSDAY, ...r meets the jubilant sports fan. , A new study ...oot for the winning team -- enjoy the greatest sat...ctory was in doubt, producing feelings of worry an...g weekend as you,re glued to the TV set, watching ...
(Date:11/26/2009)...tal (RTDental), a leading dental group practice in...sion of its services to include LUMINEERS by a cer... Durham, NC (PRWEB) -- Res...Dr. Doug Macmillan, an experienced LUMINEERS Den...aining seminar. RTDental’s ability to fulfi...
(Date:11/25/2009)...SNewswire/ -- When most people hear the acronym TM...r can also give patients the help they need. TMJ s...where your jaw (mandible) contacts/connects with y...symptoms associated with TMJ dysfunction are pain ... many other symptoms can be caused from TMJ dysfun...
Breaking Medicine News(10 mins):Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
...EL, Switzerland, March 6 Roche (SWX: ROG.VX; RO.S...price for all outstanding publicly-held shares of ...d extended the offer to 12:00 midnight, New York C...roup, said: "Based on conversations with Genentech...
... NorthShore University Health... procedure to reverse weight gain after gastric by... IL (Vocus) March 6, 2009 -- NorthShore Universit...besity Surgery Endolumenal (ROSE) is very new,&rdq...
...co listed No. 1 in Health Care: Pharmacy and Other...0 for people management worldwide , , FRANKLIN LA...NYSE: MHS ), captured the No. 1 position within ...ly, Medco was ranked No. 5 in Innovation and No. 1...
...sible Food Leader Unveils New California Veggie Po...urrito Bites at Natural Products Expo West Confere... Sensible Foods, the leader in sensible, heart-fri... Tex Mex Veggie Pockets, Falafel Flats and B...
... study finds pulsed-dye beam with topical meds imp...March 6 (HealthDay News) -- Laser therapy can safe...cne, according to a small preliminary study of 18 ...sensitizer called topical 5-aminolevulinic acid (A...
...HINGTON, March 6 The U.S. Consumer Product Safety...their smoke alarm and carbon monoxide (CO) alarm b...r Daylight Saving Time. , , (Logo: http://www.n...d," said CPSC,s Acting Chairman Nancy Nord. "Prope...
Other Medicine News:Health News:Roche Increases Offer Price for Genentech Shares to US$ 93.00 per Share and Extends Offer 2Health News:Roche Increases Offer Price for Genentech Shares to US$ 93.00 per Share and Extends Offer 3Health News:Roche Increases Offer Price for Genentech Shares to US$ 93.00 per Share and Extends Offer 4Health News:NorthShore University HealthSystem Only Hospital in the Region to Use Incisionless Procedure to Reduce Weight Regain 2Health News:NorthShore University HealthSystem Only Hospital in the Region to Use Incisionless Procedure to Reduce Weight Regain 3Health News:Medco Tops Fortune's Lists of 'World's Most Admired' Companies 2Health News:Medco Tops Fortune's Lists of 'World's Most Admired' Companies 3Health News:Dr. Praeger's Sensible Foods Launches Four New Frozen Food Products 2Health News:Dr. Praeger's Sensible Foods Launches Four New Frozen Food Products 3Health News:New Laser Combo Therapy Zaps Acne 2Health News:Replace Smoke and CO Alarm Batteries This Sunday for Daylight Saving Time 2
...l methods for patients who are drowning in chronic... effectively alleviates intervertebral compression...in is,often relieved within minutes of applicati...tment shown to decompress the spine. Using patente...
ImmuGlo Anti-Endomysial Antibody (EMA) Test System
Optical Urethrotome 8667
USA Elite System™ Visual Urethrotome
Medicine Products: